|
|
Zimmer Biomet Holdings Inc (NYSE: ZBH) |
|
|
|
| |
Zimmer Biomet Holdings Inc 's Revenue per Employee
Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales
With a revenue increase of 1.05% in the first quarter 2025, year on year to cumulative value of $7,699 million, Zimmer Biomet Holdings Inc 's revenue per employee grew on a trailing twelve months basis to $ 427,694. The productivity of Zimmer Biomet Holdings Inc 's employees was 0.0%, above the company average. Within the Healthcare sector Employees of 165 other companies have achieved higher revenue per employee. While Zimmer Biomet Holdings Inc 's total ranking has deteriorated compared to the previous quarter from 897 to 1329. Zimmer Biomet Holdings Inc has 18,000 employees.
What is Sales per Employee Ratio?
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| ZBH Revenue per Employee |
(Mar 31 2025)
I. Quarter |
(Dec 31 2024)
IV. Quarter |
(Sep 30 2024)
III. Quarter |
(Jun 30 2024)
II. Quarter |
(Mar 31 2024)
I. Quarter |
| Y / Y Revenue Change |
1.05 % |
4.29 % |
4.03 % |
3.87 % |
3.18 % |
| Sales per Employee (TTM) $ |
427,694 |
426,589 |
421,967 |
418,044 |
414,022 |
| ZBH's Total
Ranking |
# 1329 |
# 897 |
# 366 |
# 1647 |
# 0 |
| Seq. Revenue Change |
-5.64 % |
10.91 % |
-6.07 % |
2.79 % |
-2.62 % |
| Revenue per Employee Statistics |
| High |
Average |
Low |
| $ 443,456 |
$ 420,782 |
$ 385,550 |
| (Dec 31 2019) |
|
(Dec 31 2022) |
Date modified: 2025-05-06T07:42:26+00:00
| Companies with similar Revenue per Employee for 12 months ending Mar 31 2025, within Healthcare Sector | Revenue per Employee | Revenue 12 months ending Mar 31 2025 | Number of Employees Mar 31 2025 | | Quidelortho Corp | 747,216.22 | $ 2,764.700 Million | 3,700 | | Kymera Therapeutics Inc | 736,062.50 | $ 58.885 Million | 80 | | Insulet Corporation | 732,966.67 | $ 2,198.900 Million | 3,000 | | X4 Pharmaceuticals Inc | 729,395.35 | $ 31.364 Million | 43 | | Neuronetics Inc | 727,959.02 | $ 88.811 Million | 122 | | Alkermes Plc | 720,842.86 | $ 1,513.770 Million | 2,100 | | Travere Therapeutics Inc | 719,823.68 | $ 273.533 Million | 380 | | Pfizer Inc | 709,806.82 | $ 62,463.000 Million | 88,000 | | Mallinckrodt Plc | 705,925.93 | $ 1,906.000 Million | 2,700 | | Insmed Inc | 679,875.00 | $ 271.950 Million | 400 | | Henry Schein Inc | 666,789.47 | $ 12,669.000 Million | 19,000 | | Johnson and Johnson | 664,665.18 | $ 89,331.000 Million | 134,400 | | Zoetis Inc | 658,581.56 | $ 9,286.000 Million | 14,100 | | Treace Medical Concepts Inc | 640,787.23 | $ 210.819 Million | 329 | | Cerus Corporation | 637,756.94 | $ 183.674 Million | 288 | | Zai Lab Limited | 637,692.07 | $ 418.326 Million | 656 | | Intuitive Surgical Inc | 637,138.05 | $ 8,713.500 Million | 13,676 | | Orthofix Medical Inc | 632,778.91 | $ 804.262 Million | 1,271 | | Innoviva Inc | 630,174.38 | $ 408.353 Million | 648 | | Organon and Co | 629,400.00 | $ 6,294.000 Million | 10,000 | | Lifecore Biomedical Inc | 624,818.18 | $ 130.587 Million | 209 | | Phibro Animal Health Corporation | 613,444.85 | $ 1,190.083 Million | 1,940 | | Schrodinger Inc | 611,640.21 | $ 231.200 Million | 378 | | Cartesian Therapeutics Inc | 606,257.58 | $ 40.013 Million | 66 | | Emergent Biosolutions Inc | 603,375.00 | $ 965.400 Million | 1,600 | | Spero Therapeutics Inc | 594,453.33 | $ 44.584 Million | 75 | | Ginkgo Bioworks Holdings Inc | 593,542.50 | $ 237.417 Million | 400 | | Ocular Therapeutix Inc | 579,097.09 | $ 59.647 Million | 103 | | Fortress Biotech Inc | 572,118.81 | $ 57.784 Million | 101 | | Moderna Inc | 567,321.43 | $ 3,177.000 Million | 5,600 |
|
